Determination of Arsenic Content in Chinese Herbal Medicines: Analytical Methods, Standards, and App

Arsenic is one of the most strictly regulated heavy metal contaminants in traditional Chinese medicine (TCM), and its accurate determination is essential for pharmacopoeial compliance, trade certification, and patient safety. Modern laboratories quantify trace-level arsenic in herbal matrices using techniques such as inductively coupled plasma mass spectrometry (ICP-MS), hydride generation atomic absorption spectrometry (HG-AAS), and atomic fluorescence spectrometry (AFS). This article provides a technical overview of the sample types, testing items, analytical methods, quality control requirements, and practical applications involved in arsenic content determination in Chinese herbal medicines.

Technical Overview

Arsenic enters Chinese herbal materials through multiple pathways: soils with naturally high geochemical arsenic backgrounds, irrigation water contaminated by mining and smelting activities, atmospheric deposition from coal combustion, residues of arsenical pesticides and phosphate fertilizers, and contact with contaminated equipment during post-harvest processing. Root and rhizome drugs, which are in direct and prolonged contact with soil, typically show the highest accumulation potential, although leaves, barks, flowers, fruits, and seeds may also be affected.

Inorganic arsenic species, principally arsenite As(III) and arsenate As(V), are classified by the International Agency for Research on Cancer as Group 1 human carcinogens. Chronic exposure through long-term decoction consumption can cause skin lesions, peripheral neuropathy, cardiovascular effects, and increased cancer risk, which is why arsenic is treated as a high-priority safety indicator in herbal quality standards.

The Chinese Pharmacopoeia (2020 Edition) limits total arsenic to no more than 2 mg/kg in most herbal materials and decoction pieces unless an individual monograph specifies otherwise, alongside companion limits of 5 mg/kg for lead, 1 mg/kg for cadmium, 0.2 mg/kg for mercury, and 20 mg/kg for copper. The corresponding determination procedures are described in General Chapter 2321 (Determination of Lead, Cadmium, Arsenic, Mercury and Copper) together with the instrumental general chapters for atomic absorption, atomic fluorescence, and ICP-MS. For finished herbal products intended for international markets, USP chapters 232 and 233 and the ICH Q3D elemental impurities framework provide complementary risk-based requirements.

Testing Samples

Crude Herbal Materials

Raw botanical drugs—including roots, rhizomes, barks, leaves, flowers, fruits, seeds, and whole herbs—form the largest testing category. Samples are collected representatively from each lot, dried or received at their natural moisture content, and ground to a homogeneous fine powder (typically passing a 60–100 mesh sieve) before digestion.

Processed Decoction Pieces

Herbs that have been cleaned, cut, soaked, stir-fried, honey-processed, wine-processed, or carbonized are tested in their marketed form. Processing can concentrate arsenic through moisture loss or introduce contamination through auxiliary materials, so the processed article rather than the crude drug is the regulatory test object.

Extracts, Powders, and Finished Preparations

Concentrated extracts, granules, powders, pills, tablets, capsules, and oral liquids are tested both for ingredient qualification and for elemental impurity assessment of the finished product. These matrices are often more complex due to excipients and multiple herbal components, and multi-herb formulas are usually assessed on a composite or worst-case basis.

Animal-Derived and Mineral Medicinals

Marine and shellfish-derived materials may contain substantial organic arsenic species of lower toxicity, making speciation analysis important for correct risk interpretation. Intentionally arsenical mineral drugs such as realgar (arsenic sulfide) are not evaluated by total arsenic limits; instead, soluble arsenic, speciation, and bioaccessibility studies are applied.

Sampling Considerations

Reliable results depend on representative sampling, thorough homogenization in contaminant-free mills (ceramic or agate vessels are preferred), and determination of loss-on-drying so that results can be reported on a dry-weight basis. Sample handling should follow clean-trace-analysis practices to prevent cross-contamination.

Testing Items

Typical arsenic-related testing services include the following items:

• Total arsenic content, reported in mg/kg on a dry-weight basis
• Arsenic speciation, quantifying inorganic As(III) and As(V) together with monomethylarsonic acid (MMA) and dimethylarsinic acid (DMA)
• Combined heavy metals and harmful elements panels covering arsenic, lead, cadmium, mercury, and copper in a single ICP-MS run
• Water-decoction transfer studies measuring soluble arsenic transferred into the decoction under simulated clinical preparation
• Method validation parameters, including limit of detection, limit of quantification, linearity, precision, recovery, and measurement uncertainty

Testing Methods

Sample Digestion and Pretreatment

Microwave-assisted closed-vessel digestion is the preferred preparation technique. A 0.2–0.5 g portion of powdered sample is digested with 6–8 mL of high-purity nitric acid and 1–2 mL of hydrogen peroxide, ramping to 180–200 °C and holding for 20–30 minutes. The sealed system prevents volatilization losses of arsenic compounds, which can occur during open wet digestion or high-temperature dry ashing. Where dry ashing is unavoidable, a magnesium nitrate fixative is added and the temperature is kept below 550 °C. For speciation analysis, mild aqueous or methanol-water extraction under neutral conditions is used so that the original arsenic oxidation states are preserved.

Inductively Coupled Plasma Mass Spectrometry (ICP-MS)

ICP-MS is the most sensitive and information-rich approach, offering detection limits down to approximately 0.001 mg/kg and simultaneous quantification of multiple elements. Arsenic is monitored at its single isotope mass 75, where the polyatomic interference from argon chloride (40Ar35Cl+) is corrected using a helium collision cell, high-purity reagents, and chloride-minimized digestion. Germanium (72Ge) is commonly used as the internal standard. The method complies with Chinese Pharmacopoeia General Chapters 0412 and 2321 and with USP 233, and calibration linearity of r ≥ 0.999 is routinely achieved.

Hydride Generation Atomic Absorption Spectrometry (HG-AAS)

In this classical pharmacopoeial method, arsenate in the digest is first pre-reduced to arsenite with potassium iodide and ascorbic acid (or thiourea) in hydrochloric acid medium. Sodium borohydride in dilute sodium hydroxide then generates arsine gas, which is carried into a heated quartz tube for atomization and measurement at the 193.7 nm arsenic resonance line with background correction. The hydride step separates arsenic from the bulk matrix and provides detection limits of roughly 0.01–0.05 mg/kg, fully adequate for the 2 mg/kg regulatory limit.

Atomic Fluorescence Spectrometry (AFS)

Hydride generation coupled to atomic fluorescence spectrometry, described in Chinese Pharmacopoeia General Chapter 0411, combines extremely low detection limits (nanogram-per-liter levels in solution) with low instrument cost and simple operation. After the same pre-reduction chemistry as HG-AAS, arsine is atomized in an argon–hydrogen flame and the resulting fluorescence intensity is compared with calibration standards. AFS is widely used in Chinese testing laboratories for single-element arsenic and mercury determination.

Speciation Analysis by HPLC-ICP-MS

When the toxicological relevance of total arsenic is questioned, anion-exchange HPLC with ammonium phosphate mobile phase separates As(III), As(V), MMA, and DMA within approximately 15 minutes, with ICP-MS providing element-specific detection. Summing the two inorganic species gives the health-relevant inorganic arsenic figure, which is particularly valuable for marine-derived materials and for distinguishing genuine risk from benign organic arsenic.

Legacy Colorimetric Method

The silver diethyldithiocarbamate (Ag-DDC) colorimetric method, in which generated arsine reacts with Ag-DDC reagent and absorbance is read at 510 nm, remains a historical reference in older monographs but has largely been superseded by instrumental techniques.

Quality Control and Method Validation

Each analytical batch includes reagent blanks, duplicate samples, certified reference materials of botanical matrix (such as tea leaf or herb powder CRMs), and spiked recovery samples, with recoveries typically required within 80–120% and repeatability RSD below 5%. Accredited laboratories operate under ISO/IEC 17025 management systems, apply internal standard drift correction, and report results with measurement uncertainty and stated detection limits.

Applications

Arsenic determination supports the entire lifecycle of Chinese herbal medicines, from cultivation to clinical use:

• Pharmacopoeial compliance testing and batch release of crude drugs, decoction pieces, and finished preparations
• Market surveillance and enforcement actions by drug regulatory authorities
• Environmental assessment of Good Agricultural Practice (GAP) cultivation bases, including soil–herb arsenic transfer studies
• Import and export inspection and issuance of conformity certificates for international trade
• Elemental impurity risk assessment of finished TCM products under ICH Q3D and USP frameworks
• Scientific research on geochemical background values, processing effects, and decoction transfer rates of arsenic

FAQ

What is the regulatory limit for arsenic in Chinese herbal medicines?

The Chinese Pharmacopoeia limits total arsenic to 2 mg/kg or less in most herbal materials and decoction pieces, unless an individual monograph specifies a different limit. Finished products for international markets may instead be evaluated against risk-based permitted daily exposure values under USP 232 or ICH Q3D.

Which analytical method should be chosen for routine testing?

ICP-MS is the first choice when multi-element screening and the lowest detection limits are required; HG-AAS and AFS are cost-effective, highly sensitive options focused on arsenic alone. All three approaches, when properly validated, satisfy pharmacopoeial requirements.

Why measure inorganic arsenic separately from total arsenic?

Toxicity is driven primarily by the inorganic species As(III) and As(V), while organic arsenic compounds such as arsenobetaine are far less hazardous. Speciation by HPLC-ICP-MS distinguishes these forms and prevents misclassification of risk in materials containing predominantly organic arsenic.

How is arsenic loss prevented during sample preparation?

Closed-vessel microwave digestion with nitric acid and hydrogen peroxide keeps arsenic in solution under pressure, eliminating the volatilization losses that occur with open high-temperature ashing. When ashing is necessary, magnesium nitrate is added as a fixative and temperatures are strictly controlled.

How should test results be reported?

Results are reported in mg/kg on a dry-weight basis, together with the analytical method used, the limit of detection, recovery and CRM data from the analytical batch, and, where required, the expanded measurement uncertainty.